Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial
Open Access
- 15 April 1993
- Vol. 71 (8), 2515-2521
- https://doi.org/10.1002/1097-0142(19930415)71:8<2515::aid-cncr2820710814>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin DiseaseAnnals of Internal Medicine, 1992
- Use of Very-High-Dose Chemotherapy With Autologous Bone Marrow Transplantation in Treatment of Breast CancerJNCI Journal of the National Cancer Institute, 1992
- GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimenThe Lancet, 1991
- Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.Journal of Clinical Oncology, 1990
- Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy?Hematological Oncology, 1989
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988
- Monoclonal Antibodies Detect Occult Breast Carcinoma Metastases in the Bone Marrow of Patients with Early Stage DiseaseThe American Journal of Surgical Pathology, 1988
- GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MANThe Lancet, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988